Shandong Realcan Pharmaceutical Co Ltd (002589) — Cash Flow Quality Index
Shandong Realcan Pharmaceutical Co Ltd (002589) has a Cash Flow Quality Index of 6.22x as of June 2025. Operating cash flow of CN¥24.86 Million exceeds net income of CN¥4.00 Million, indicating high earnings quality where cash backs reported profits. Explore cash flow conversion of Shandong Realcan Pharmaceutical Co Ltd to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shandong Realcan Pharmaceutical Co Ltd Cash Flow Quality Index (2008–2025)
Historical Cash Flow Quality Index for Shandong Realcan Pharmaceutical Co Ltd across 16 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Shandong Realcan Pharmaceutical Co Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Shandong Realcan Pharmaceutical Co Ltd (2008–2025)
Year-by-year earnings quality comparison for Shandong Realcan Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see Shandong Realcan Pharmaceutical Co Ltd stock valuation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.86x | CN¥13.76 Million | CN¥16.07 Million | ▼ -78.1% |
| 2024 | 3.91x | CN¥160.44 Million | CN¥41.02 Million | ▼ -3.6% |
| 2023 | 4.06x | CN¥82.47 Million | CN¥20.32 Million | ▲ +250.0% |
| 2021 | 1.16x | CN¥442.95 Million | CN¥382.01 Million | ▲ +74.5% |
| 2020 | 0.66x | CN¥414.96 Million | CN¥624.55 Million | ▲ +521.0% |
| 2018 | -0.16x | CN¥-201.66 Million | CN¥1.28 Billion | ▲ +91.1% |
| 2017 | -1.77x | CN¥-2.42 Billion | CN¥1.37 Billion | ▲ +32.1% |
| 2016 | -2.61x | CN¥-1.76 Billion | CN¥675.07 Million | ▼ -35.9% |
| 2015 | -1.92x | CN¥-466.26 Million | CN¥243.13 Million | ▼ -113.0% |
| 2014 | -0.90x | CN¥-163.62 Million | CN¥181.76 Million | ▲ +52.7% |
| 2013 | -1.90x | CN¥-274.46 Million | CN¥144.24 Million | ▼ -23.5% |
| 2012 | -1.54x | CN¥-170.52 Million | CN¥110.67 Million | ▲ +72.7% |
| 2011 | -5.65x | CN¥-475.03 Million | CN¥84.02 Million | ▼ -597.9% |
| 2010 | 1.14x | CN¥70.56 Million | CN¥62.13 Million | ▼ -17.1% |
| 2009 | 1.37x | CN¥61.38 Million | CN¥44.81 Million | ▲ +180.1% |
| 2008 | -1.71x | CN¥-49.88 Million | CN¥29.18 Million | — |